Single dose comparative bioavailability study of controlled release carvedilol formulations RHB 101 and Coreg CR

Trial Profile

Single dose comparative bioavailability study of controlled release carvedilol formulations RHB 101 and Coreg CR

Planning
Phase of Trial: Phase I

Latest Information Update: 07 Jun 2013

At a glance

  • Drugs Carvedilol (Primary)
  • Indications Heart failure; Hypertension
  • Focus Pharmacokinetics
  • Most Recent Events

    • 07 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top